Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06177639 · ClinicalTrials.gov registry record
Widefield Confocal Scanning Laser Ophthalmoscope Optimized for Pediatric and Neonatal Imaging
A clinical trial of Eye Diseases, sponsored by Duke University.
- Recruiting
- Registry status
- 42
- Enrollment target
- 1
- Study location
NCT06177639: Recruiting study of Eye Diseases, sponsored by Duke University.
NCT06177639 is a study of Eye Diseases that is actively recruiting participants, run by Duke University. The registered enrollment target is 42 participants, below the 741,301-participant average among 27 other Eye Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06177639, a study of Eye Diseases, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to test the use of a novel Widefield Confocal Scanning Laser Ophthalmoscope (WiSLO) Optimized for Pediatric and Neonatal Imaging in pediatric and adult subjects who are undergoing clinical evaluation for eye disease or are healthy adult volunteers. The main questions to answer are: * Whether WiSLO will be more comfortable and satisfactory in experience for the patient and operator than commercial alternatives. * If the quality of WiSLO near infrared images will be comparable to color fundus camera imaging across population of different ages and fundus pigmentation. Participants will have the following research procedures: * Imaging of both eyes with a research noncontact WiSLO * Imaging of both eyes with a commercially available non-contact hand held fundus camera (Volk Pictor Plus) * Likert scales for adults * Pediatric Likert scales for children * CRIES scales for infants.
Primary Outcome
Presence (Yes/No) of retinal anatomy as measured from WiSLO and commercial OCT grading
Conditions Studied
Interventions
- DEVICE WiSLO
- DEVICE Volk Pictor Plus™
Study Locations (1)
North Carolina
- Duke University Eye Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2026-08 |
What NCT06177639 shows while recruiting
NCT06177639 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 741,301-participant average among 27 other Eye Diseases trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Eye Diseases appearing as the primary indexed condition, and to 2 interventions - of which WiSLO is the first listed.
NCT06177639 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06177639 about?
NCT06177639 is a clinical study titled "Widefield Confocal Scanning Laser Ophthalmoscope Optimized for Pediatric and Neonatal Imaging". The goal of this observational study is to test the use of a novel Widefield Confocal Scanning Laser Ophthalmoscope (WiSLO) Optimized for Pediatric and Neonatal Imaging in pediatric and adult subjects who are undergoing clinical evaluation for eye disease or are healthy adult volunteers. The main q...
What is the current status of trial NCT06177639?
This trial is currently recruiting. The enrollment target is 42 participants. The study started on 2025-10-01. Estimated completion is 2026-08.
What conditions does trial NCT06177639 study?
This clinical trial studies the following conditions: Eye Diseases.
What interventions are being tested in trial NCT06177639?
The interventions under investigation include: WiSLO (DEVICE), Volk Pictor Plus™ (DEVICE).
Who is sponsoring clinical trial NCT06177639?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06177639 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eye Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06177639's enrollment target sits among peer trials
42 18th of 27 higher than 10 of 27 other Eye Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eye Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adaptive Optics Retinal Imaging
RECRUITING
-
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RECRUITING · Phase 3
-
SGLT2 Inhibitors in Geographic Atrophy
RECRUITING · Phase 2
-
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
RECRUITING · NA
-
IRIS Registry: Intelligent Research in Sight Registry
RECRUITING
-
Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI